Eye Diseases: all 747 studies
Page 7 of 8. Open to participants first (118), then studies with results posted, then the rest; newest registration first within each.
- Optic Disc, Macula, and Retinal Nerve Fiber Layer Measurements Obtained by OCT in Thyroid Associated OphthalmopathyCompletedNCT02766660Not applicable
- In Vivo Confocal Microscopic Analysis of Corneal Nerve Changes After ProKera Slim® for Dry EyeCompletedNCT02764814Not applicable
- Graves' Orbitopathy and HypercholesterolemiaCompletedNCT02721992
- SD-OCT Multimodal Analysis in GLaucomaCompletedNCT02710916Not applicable
- New Treatment for Patients With Temporal Hollowing After Lateral Wall DecompressionCompletedNCT02693808Not applicable
- A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye DiseaseCompletedNCT02665234Phase 3
- Micro vs. Standard Trabeculectomy StudyCompletedNCT02598765Not applicable
- New Imaging Technology to Assess Effect of Enzyme Replacment Therapy on Eye Disease Progession in MucopolysacchardiosisStatus unknownNCT02583152
- CLEAR SIGHT: A Trial of Non-Mydriatic Ultra-Widefield Retinal Imaging to Screen for Diabetic Eye DiseaseCompletedNCT02579837Not applicable
- Optical Coherence Tomography of Tear Film Dynamics In-VivoCompletedNCT02554084Not applicable
- Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMDCompletedNCT02543229Phase 1
- The Effects of Metformin in Patients With Mild Graves' OphthalmopathyStatus unknownNCT02535975Not applicable
- Characterization of Potential Biomarkers of Eye Disease and VisionActive, not recruitingNCT02500862
- Ultrasound Guided Peribulbar Anaesthesia - A Novel Dual Quadrant Injection TechniqueCompletedNCT02459782Not applicable
- The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye DiseaseWithdrawnNCT02422368Phase 2/3
- Tear Osmolarity Clinical Utility in Dry Eye DiseaseCompletedNCT02417116Not applicable
- Study of EBI-005 in Dry Eye Disease (DED)Status unknownNCT02405039Phase 3
- mDixon TSE MRI Sequence And Conventional MRI Sequences In Dysimmune Orbitopathies (DDX)CompletedNCT02397109
- Intravitreal Injections by Nurses and Physicians ComparedCompletedNCT02359149Not applicable
- Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye DiseaseStatus unknownNCT02339142Phase 4
- Sparing of the Fovea in Geographic Atrophy ProgressionCompletedNCT02332343
- The Effect of Resveratrol Based Nutritional Supplement on Choroidal ThicknessStatus unknownNCT02321189Not applicable
- Pharmacokinetics of Trans-resveratrol Based Nutritional Supplement and Its Three Metabolites in Human Eyes and BloodStatus unknownNCT02321176Not applicable
- B-cell Depletion Therapy With Rituximab for Thyroid Eye DiseaseTerminatedNCT02316691
- Topical Diclofenac on Macular Thickness After PhacoemulsificationStatus unknownNCT02306031Phase 2
- Retinal Oxygen Saturation in Patients With Graves' Ophthalmopathy and in Normal PeopleStatus unknownNCT02290704
- The Influence of PRN Omega-3 Nutritional Supplement on Visual AcuityStatus unknownNCT02260973Phase 2/3
- The Influence of PRN Dry Eye Omega-3 Nutritional Regimen on Tear Osmolarity In Cases Of Dry Eye DiseaseCompletedNCT02260960Phase 2/3
- Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye DiseaseCompletedNCT02242032Phase 1
- Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye DiseaseCompletedNCT02229955Phase 3
- Doxycycline Treatment in Mild Thyroid-Associated OphthalmopathyStatus unknownNCT02203682Phase 2
- Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin AnaloguesCompletedNCT02155049Phase 3
- Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular HypertensionCompletedNCT02136940Phase 2
- Selenium in Mild Thyroid Eye Disease in North AmericaWithdrawnNCT02112643Phase 3
- Comparison of Non-mydriatic Camera Systems in a Female Health HospitalCompletedNCT02089009Not applicable
- Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study)CompletedNCT02059655Phase 4
- Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca)CompletedNCT02051023Phase 3
- Ocular Surface Immune Response in Dry Eye DiseaseCompletedNCT02042820
- A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®WithdrawnNCT02028312Phase 4
- Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye DiseaseCompletedNCT02004067Phase 4
- A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy SubjectsCompletedNCT02003547Phase 1
- Improving Follow-Up Adherence in a Primary Eye Care SettingCompletedNCT02001129Not applicable
- Comparison Study Between Two Techniques for Correction of Upper Lid Retraction in Patients With Grave's OrbitopathyStatus unknownNCT01999790Not applicable
- Phase 3 Study of EBI-005 in Dry Eye DiseaseCompletedNCT01998802Phase 3
- A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' OrbitopathyStatus unknownNCT01969019Phase 4
- The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.WithdrawnNCT01927406Phase 4
- Study of the Effects of Supplements on Eye Disease in Participants From the Age-Related Eye Disease StudyCompletedNCT01915238
- Bromocriptine and Pentoxifylline in Ophthalmopathy Autoimmune TreatmentTerminatedNCT01893450Not applicable
- Dry Eye Disease in the Vitamin D and Omega-3 Trial (VITAL)Status unknownNCT01880463Not applicable
- Living Successfully With Chronic Eye DiseasesStatus unknownNCT01879501Not applicable
- The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma StudyCompletedNCT01857440
- Systane Ultra Versus Maxidex Versus SalineCompletedNCT01775540Not applicable
- Visual Performance of Pseudophakic Patient With Different Intraocular LensesStatus unknownNCT01763411
- Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye DiseaseWithdrawnNCT01753596Phase 3
- Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic RetinopathyCompletedNCT01746563Phase 1/2
- Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye DiseaseTerminatedNCT01738243Phase 4
- Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' OrbitopathyCompletedNCT01727973Phase 1/2
- Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle GlaucomaCompletedNCT01693315Phase 2
- A Study of RX-10045 in the Treatment of Dry Eye DiseaseCompletedNCT01675570Phase 2
- iCam Clinical Validation StudyCompletedNCT01600261
- Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone InjectionsCompletedNCT01599273Phase 4
- The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated OphthalmopathyCompletedNCT01579539Phase 3
- Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye DiseaseCompletedNCT01562795Not applicable
- Blood and Saliva Sample Collection for AREDS 2CompletedNCT01553474
- An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular DegenerationStatus unknownNCT01521065Phase 2
- Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular DegenerationCompletedNCT01494805Phase 1/2
- A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye DiseaseWithdrawnNCT01478555Phase 2
- A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye PatientsCompletedNCT01468168Phase 2
- Optical Coherence Tomography (OCT) Data Collection StudyCompletedNCT01459731
- Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)CompletedNCT01458600Phase 4
- Efficacy and Safety of Oral Valproic Acid for Retinitis PigmentosaCompletedNCT01399515Phase 2
- Trying a New Device for Performing Capsulorhexis in Cataract Surgery SurgeryStatus unknownNCT01396967Phase 1
- Use of Azithromycin as Immunomodulatory Therapy in Grave&Apos;s OrbitopathyWithdrawnNCT01379196Phase 1/2
- UVA-Riboflavin Crosslinking Treatment of Corneal EctasiaStatus unknownNCT01325298Phase 2
- Diurnal Variation in Tear OsmolarityCompletedNCT01321424
- Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)CompletedNCT01297699Phase 3
- Use of Botox in the Management of Thyroid Related Upper Eyelid RetractionWithdrawnNCT01272414Phase 4
- Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMDWithdrawnNCT01256580Not applicable
- Creation of the Biobank Related to Eye DiseaseCompletedNCT01240343
- Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye DiseaseCompletedNCT01239069Phase 2
- Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)Status unknownNCT01217762Phase 1
- The Effect of Early Total Thyroidectomy in the Course of Graves' OrbitopathyStatus unknownNCT01056419Phase 4
- Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)CompletedNCT01024998Phase 1
- A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye DiseaseCompletedNCT01014078Phase 4
- The DIOXXACT Trial(Diurnal IOP and OBF Xalatan vs Xalatan And Cosopt Trial)CompletedNCT00957190Phase 4
- Pilot Study to Determine Safety and Efficacy of Orbital Injections of LIPO-102 in Patients With Symptomatic Exophthalmos Associated With Thyroid-related Eye Disease (TED)CompletedNCT00954057Phase 2
- Patient Specific Induced Pluripotency Stem Cells (PSiPS)CompletedNCT00953693
- Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG)CompletedNCT00913029Phase 4
- A Prospective, Unmasked Evaluation of the iStent in Patients With Primary Open-Angle GlaucomaCompletedNCT00911924Phase 4
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637)CompletedNCT00831662Phase 3
- Fundus Changes in the Microphthalmy EyesCompletedNCT00811512
- Assessment of Inflammatory and Functional Changes in the Ocular Surface Associated With Dry Eye DiseaseCompletedNCT00809003
- Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®CompletedNCT00799682Phase 4
- Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up TimeCompletedNCT00760045Phase 2
- The Evaluation of Thiol Redox Status in Conjunctiva of Dry Eye PatientsStatus unknownNCT00718926
- Evaluation and Treatment of People With Eye DiseasesCompletedNCT00708955
- Color Doppler Imaging of Orbital Venous Flow in Grave's OrbitopathyCompletedNCT00697528
- A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic SolutionCompletedNCT00680108Phase 2
- A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye DiseaseCompletedNCT00679718Phase 2
- Validation of Computerized Vision-Targeted Quality-of-Life QuestionnairesCompletedNCT00678860